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Summary
Objective: To compare characteristics of patients with severe osteoarthritis with and without calcium pyrophosphate dihydrate (CPPD) crystal
deposition disease.
Study methods: Patients undergoing total knee replacement surgery participated in this study and completed questionnaires. Radiographs of
the index knee (extended anteroposterior, lateral and skyline) were reviewed for the presence of chondrocalcinosis. Synovial ﬂuids were
obtained during surgery and analyzed under compensated polarized light microscopy.
Results: The presence of CPPD crystals was identiﬁed in 52.9% of 102 patients. The use of both radiographs and synovial ﬂuid analysis in-
creased the identiﬁcation of crystals. There was no difference in the following characteristics of the patients with and without CPPD crystals:
age of pain onset, gender, difﬁculty in performing daily functions (including cooking, standing up from chairs, using restroom, going upstairs,
and going shopping), history of previous joint inﬂammation, use of walking aids, and number and types of medications ever used. CPPD
patients underwent knee arthroplasty at older age compared to non-CPPD patients (70.3 6.37 and 67.5 7.15 years old, respectively)
(P¼ 0.037). All but one CPPD patients were unaware of the presence of crystals.
Conclusion: High prevalence of CPPD crystals was found in patients undergoing total knee replacement surgery. All but one CPPD patients
were unaware of calcium deposition in the index joints. Patients with these crystals experienced similar difﬁculties in performing daily activities
and received similar treatment to patients without CPPD crystals. CPPD patients did not undergo knee arthroplasty at earlier age than non-
CPPD patients.
ª 2006 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) of the knees is very common in the
elderly. Its prevalence increases with age. Radiographic
knee OA is evident in 33% in those aged 63 and older in
the Framingham study1. Co-existence of degenerative ar-
thritis and calcium pyrophosphate dihydrate (CPPD) crystals
is well-documented. Calcium-containing crystals, including
CPPD and basic calcium phosphate crystals, are found in
60% of osteoarthritic synovial ﬂuids from patients with OA
at the time of total knee arthroplasty (TKA)2. Prevalence of
CPPD crystals in Thai population with degenerative arthritis
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diographic hallmark of CPPD deposition disease, have an in-
creased rate of radiographic OA and more advanced
radiographic progression3,4. Patients with OA of the knee
who also have chondrocalcinosis and CPPD crystals in sy-
novial ﬂuids are more disabled than patients without at the
time of hospital referral5. In another study, patients with
CPPD crystals in their osteoarthritic knees are more likely
to be symptomatic than asymptomatic6.
The aim of this study is to compare clinical characteristics
of patients, with and without CPPD crystal deposition dis-
ease (CPPDDD), who underwent total knee replacement
surgery and to compare treatment patterns between them.
Materials and methods
This cross-sectional study was approved by the Ethics
Committee at King Chulalongkorn Memorial Hospital (Bang-
kok, Thailand). Consent forms were obtained from consec-
utive patients undergoing TKA for OA between January
2004 and July 2004. OA was diagnosed by 1986 American
College of Rheumatology criteria for OA7. Questionnaires2
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records were also reviewed.
QUESTIONNAIRES
We obtained the following data: age, gender, previous di-
agnosis of crystal deposition disease, previous history of
calcium deposition in cartilage, previous history of acute
inﬂammatory attack in the index knee (deﬁned by the pres-
ence of two of the following: pain, redness, warmth, swell-
ing), use of walking aids, types of treatment received prior
to surgery, and satisfaction level of non-surgical treatment
(0¼ unsatisfactory, 5¼ very satisfactory). Difﬁculty level in
performing activities of daily living including using restroom,
cooking, standing up from a chair, going shopping and go-
ing upstairs was recorded as 0 (no difﬁculty), 1, 2, 3, 4 and 5
(almost impossible to perform). Patients were asked to give
the number of days in a regular month that they did not
leave home because of problems (such as pain) in the in-
dex knees. They also reported number and types of educa-
tion provided by their physicians (weight loss, general
exercise, quadriceps exercise, instructions on use of medi-
cations, lifestyle modiﬁcation and other topics). Age of onset
was divided into 10-year age groups starting from 41e50-
year-old group to 71e80-year-old group.
SYNOVIAL FLUID COLLECTION
Fluids were collected into syringes without anticoagulant
and examined within 24 h.
RADIOGRAPHS
Chondrocalcinosis of index knees was determined by
conventional radiographs. Weight-bearing extended antero-
posterior, lateral and supine skyline ﬁlms were obtained in
the year prior to surgery. A musculoskeletal radiologist
was available to conﬁrm the presence of calciﬁcation in sus-
picious ﬁlms.
COMPENSATED POLARIZED LIGHT MICROSCOPY
One drop of each uncentrifuged ﬂuid was analyzed for
CPPD crystals using a compensated polarized light micro-
scope. CPPD crystals appear as weakly, positively birefrin-
gent or non-birefringent rod- or rhomboid-shaped crystals.
Visualization of at least one such crystal by two observers
was necessary to conﬁrm the presence of CPPD crystals.
At least 40 high power ﬁelds were examined for each
specimen.
Diagnostic criteria for CPPDDD have been proposed al-
though its sensitivity and speciﬁcity are not deﬁned. Deﬁnite
diagnosis is entertained when a crystal is identiﬁed by X-ray
or electron diffraction, infrared spectroscopy or chemical
analysis; or radiographic chondrocalcinosis is present in
conjunction with a crystal visualized by polarized light mi-
croscopy. Probable diagnosis is entertained in the presence
of either chondrocalcinosis or crystals under microscope.
Finally, possible diagnosis is entertained when acute at-
tacks especially in knees or wrists or chronic arthritis are
present in any combination8.
STATISTICAL ANALYSES
Statistics was performed using SPSS software version
11.5. Test for association between baseline characteristicsand the presence of CPPD deposition was performed using
Pearson’s Chi-square, continuity correction, Fisher’s exact
test and linear by linear association. Difﬁculty levels in per-
forming activities and satisfaction to pre-surgical treatment
were compared using ManneWhitney U test. One patient
with Parkinson’s disease was excluded from difﬁculty level
analyses. Student’s t test was used to compare continuous
data. The signiﬁcance level was set at P< 0.05.
Results
One hundred and two patients consented to the study.
Synovial ﬂuids were obtained from all patients and complete
questionnaires from 100 patients. Radiographs were found
in 100 patients.
Women accounted for 80.2% of 102 subjects. Mean age
of all patients was 68.96 6.84 years. CPPD crystal was
present in synovial ﬂuid of one patient of whom radiographs
were missing and was absent in the other. In 100 patients of
whom both synovial ﬂuids and radiographs were available,
CPPD crystals were found in synovial ﬂuids from 43 pa-
tients and chondrocalcinosis was present on radiographs
from 35 patients. Twenty-ﬁve patients had both synovial
ﬂuid crystals and chondrocalcinosis and, therefore, had def-
inite diagnosis of CPPDDD. The prevalence of CPPDDD,
including both deﬁnite and probable diagnosis, is 52.9%.
Patient characteristics were compared between those
with and without CPPD deposition (Table I). After excluding
one patient with incomplete questionnaire, there were 53
patients with (CPPD group) and 48 patients without (OA
group) CPPD deposition. Women accounted for 73.6%
(39/53) in the CPPD group and 87.5% (42/48) in the
OA group. Their average ages were 70.3 6.37 and
67.5 7.15 years old, respectively (P¼ 0.037). The onset
of pain in the index knees before an age of 60 years is
not different statistically (39.6% in CPPD group and
Table I
Comparison of characteristics of patients with OA with (CPPD) and
without (OA) CPPD deposition disease
Characteristics CPPDDD
(%) (N¼ 53)
OA (%)
(N¼ 48)
P
value
Female gender 39 (73.6) 42 (87.5) 0.133
Age (mean (sd)) 70.3 (6.37) 67.5 (7.15) 0.037
Pain onset
before age 60
21 (39.6) 28 (58.3) 0.093
Previous inﬂammation 24 (45.3) 22 (45.8) 1.000
History of calcium crystal 2 (3.8) 1 (2.1) 1.000
Previous knee replacement 13 (24.5) 5 (10.4) 0.112
Difﬁculty level <3 (n¼ 100)
Cooking 16 (30.8) 19 (39.6) 0.476
Standing up 14 (26.9) 14 (29.2) 0.979
Using toilets 19 (36.5) 20 (41.7) 0.749
Walking upstairs 2 (3.8) 3 (6.4) 0.664
Going shopping 5 (9.4) 4 (8.5) 1.000
Use walking aids (n¼ 100) 28 (52.8) 26 (54.2) 1.000
Any educations provided 46 (86.8) 44 (91.7) 0.642
Number of medications
ever used (>3)
20 (37.7) 16 (33.3) 0.800
Paracetamol 31 (58.5) 33 (68.8) 0.389
Tramadol 7 (13.2) 8 (16.7) 0.835
NSAIDs 23 (43.4) 11 (22.9) 0.050
Cox-2 inhibitors 40 (75.5) 39 (81.3) 0.645
Glucosamine/chondroitin 5 (9.3) 2 (4.3) 0.445
Herbal/Chinese medicine 10 (18.9) 7 (14.6) 0.758
Gel, cream, ointment 42 (79.2) 43 (89.6) 0.251
Intraarticular injection 7 (13.2) 11 (22.9) 0.311
Physical therapy 14 (26.4) 12 (25) 1.000
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tients who reported previous inﬂammation actually had
CPPDDD using deﬁnite or probable diagnostic criteria. Sim-
ilar number of patients in both groups reported inﬂammation
in the index knee (45.3% in CPPD group and 45.8% in OA
group, P¼ 1.000). History of calcium crystals in the index
knee was inquired in a separate question and was reported
in only three patients and history of gout in two. Previous
knee replacement was reported by 24.5% of CPPD patients
and by 10.4% of OA patients (P¼ 0.112).
We undertook this study to ﬁnd out if daily activities in pa-
tients who had CPPDDD in degenerative joints at the time
of TKA were more affected than in patients without
CPPDDD. Self-reported difﬁculty in performing various ac-
tivities, namely cooking, standing up from a sitting position,
using restrooms, going upstairs and going shopping, was
not different among the two groups by ManneWhitney
U test (P¼ 0.25, 0.77, 0.88, 0.41 and 0.36, respectively).
When ﬁve difﬁculty levels were divided into two groups:
low level of difﬁculty (0, 1, 2) and high level of difﬁculty (3,
4, 5), no difference was found (Table I). This result was sup-
ported by the similar number of patients in both groups us-
ing walking aids and wheelchairs (P¼ 1.000).
We then looked into treatment received by each group.
The most commonly used medications in both groups
were topical agents (gel, cream, ointment) in 80e90% and
coxibs in 75e80%. The use of conventional non-steroidal
antiinﬂammatory drugs (NSAIDs), coxibs, glucosamine
and chondroitin sulfate, topical agents and intraarticular in-
jection of steroid and hyaluronan was not different between
the two groups (Table I). CPPD patients (43.4%) used
NSAIDs more than non-CPPD patients (22.9%) but this
did not reach statistical signiﬁcance (P¼ 0.050). CPPDDD
did not inﬂuence patient education on various topics by their
physicians and common rehabilitation techniques either
(Table I). Evaluation of satisfaction of non-surgical treat-
ment prior to surgery was not different between the two
groups by ManneWhitney U test (P¼ 0.073).
Discussion
This cross-sectional study revealed that the prevalence of
CPPDDD in severe degenerative arthritis is as high as
52.9%. Only one of 102 patients was aware of calcium crys-
tal deposition in the index joint prior to this study. Daily ac-
tivities in these patients with CPPDDD were as much
affected as those without CPPDDD. Treatment received
by these two groups of patients was similar in terms of num-
ber and types of medications and rehabilitative regimens.
CPPD patients underwent TKA in their index knee at older
age than non-CPPD patients. Similar number of CPPD and
non-CPPD patients had underwent arthroplasty in the non-
index knees. There was also no difference in their satisfac-
tion with the pre-surgical treatment.
Our study conﬁrms that calcium crystal deposition dis-
ease is highly prevalent in knee joints with severe degener-
ative arthritis in Thai patients. Other studies have shown
varying prevalence depending on the method of crystal
detection2, 9,10. Practical methods include crystal analysis
under compensated polarized light microscopy and radiog-
raphy, both of which are hampered with low sensitivity but
are widely available. Using both methods increased our de-
tection ability. The prevalence of 52.9% in our patients is
higher than the Framingham study which revealed the prev-
alence of radiographic knee chondrocalcinosis in population
aged 63e93 to be 33%; in population younger than 70years old to be 27% and in population older than 80 years
old to be 44%1. However, another study conducted in
patients undergoing knee replacement surgery, representing
the same population as ours, revealed the prevalence of
calcium crystal deposition disease to be as high as 60%2.
In Kuwait, 0.5% of total patients who were evaluated at
one rheumatology clinic over 5 years were diagnosed with
CPPDDD11. The role of calcium crystal in OA has been
reviewed4,12,13.
We were interested in the functional abilities of patients
with CPPDDD and those without. We asked our patients
of difﬁculty level (0¼ not difﬁcult; 5¼ almost impossible to
perform) in carrying out activities of daily living including
cooking, standing up from a sitting position, using rest-
rooms, going upstairs and going shopping. There was no
difference between the two groups in any of these activities
(Table I). We conclude that in our patients with end-stage
degenerative arthritis, the presence of CPPD crystals did
not worsen their functional ability. This may not hold true
in patients with early degenerative arthritis with CPPD crys-
tals. Other studies have also shown more symptoms, more
disability and more radiographic progression in CPPDDD
than in OA5,6,14. Despite the results of these studies, our
CPPD patients underwent arthroplasty in the index knees
at older age than non-CPPD patients. Our study is consis-
tent with a recent longitudinal Magnetic resonance imaging
study which shows no association between the presence
of chondrocalcinosis in knee joints and cartilage loss15.
Another type of calcium crystals, basic calcium phosphate
crystal, is related to rapid progression of radiographic
OA16. The concentration of this crystal is correlated with
the Kellgren and Lawrence radiographic score2. Five mech-
anisms by which basic calcium phosphate crystals may
cause tissue damage have been delineated in detail and
include the induction of mitogenesis, the upregulation of
matrix metalloproteinase production, the stimulation of
cyclooxygenases 1 and 2 and prostaglandin E2 production,
the stimulation of cytokine production and the induction of
nitric oxide production17.
As previous study has shown more disability and severity
in CPPDDD as compared to OA5, we studied if CPPD pa-
tients used more medications than OA patients. We found
that they employed similar treatment regimens. Reasons
for this are several. Most importantly, no speciﬁc treatment
is available for CPPDDD. Symptomatic treatment is often
employed. CPPD patients might have been expected to
have inﬂammation at some point of degenerative arthritis
and to use more NSAIDs and coxibs. Yet, physicians
were unaware of CPPDDD in this group and comparable
number of patients in both group reported sign of inﬂamma-
tion (P¼ 1.000). During the time of the study, coxibs were
very popular and were used by approximately 75e80% of
both groups (P¼ 0.645). Some of our CPPD patients
used glucosamine and chondroitin sulfate. These agents
have not been studied in clinical trials designed speciﬁcally
for CPPDDD. As we found CPPD deposition in 52.9% of our
patients, we believe that clinical trials of these agents in-
volving osteoarthritic patients included patients with CPPD
deposition. Considering all the similarities of functional dis-
abilities and treatment regimens, osteoarthritic patients with
and without CPPD deposition were satisﬁed with their pre-
surgical treatment to the similar extent.
Our study is a cross-sectional study. Recall bias is an im-
portant limitation. We attempted to solve this problem by ex-
tracting data from medical records of all patients. However,
the study site is a tertiary care center, which led to referral
for surgery from other hospitals (both private and
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medical records were not available for reviews. For the
same token, our study is generalizable as it represents
the practice of physicians both in primary and tertiary care
setting. Another limitation is the selection bias as we re-
cruited only patients at their end stage of OA, which might
have led to similarity in most characteristics of patients
with and without CPPDDD.
We did not use standard measures of functional abilities
such as Western Ontario and McMaster Universities score,
or Lequesne’s algofunctional index. Instead, we decided to
use activities normally performed by elderly Thai people
and omitted activities rarely performed in Thailand such
as wearing/removing socks. OA score designed for use
for Thai people is under development.
In conclusion, high prevalence of CPPD crystals was
found in patients undergoing total knee replacement sur-
gery. Patients with these crystals experienced similar difﬁ-
culties in performing daily activities at the time of knee
replacement surgery and received similar treatment to pa-
tients with severe OA without CPPD crystals. Osteoarthritic
patients with CPPD deposition had joint replacement sur-
gery at older age than those without.
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